Aditxt, Inc. Derivative Underlying Investment Shares
Aditxt, Inc. (ADTX) had Derivative Underlying Investment Shares of 698.82 thousand shares as of 2026-02-13, per its 10-Q filed 2026-05-20.
Financial Statements › Notes
us-gaap:DerivativeUnderlyingInvestmentShares · last filed 2026-05-20
- 2026-02-13: Derivative Underlying Investment Shares 698.82K shares.
| Period end | Derivative Underlying Investment Shares |
|---|---|
| 2026-02-13 | 698.82K shares 10-Q · filed 2026-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |